ConvaTec Group Plc (CNVVF)
USD 2.89
(0.0%)
USD 2.89
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 455.5 Million USD | 22.79% |
| 2022 | 340.98 Million USD | 2.93% |
| 2021 | 395.52 Million USD | -0.12% |
| 2020 | 448.66 Million USD | 34.37% |
| 2019 | 321.49 Million USD | -31.44% |
| 2018 | 440.8 Million USD | -1.86% |
| 2017 | 423.84 Million USD | 33.46% |
| 2016 | 271.15 Million USD | -15.49% |
| 2015 | 334.75 Million USD | 2.82% |
| 2014 | 387.4 Million USD | -22.19% |
| 2013 | 497.9 Million USD | 5.76% |
| 2012 | 470.8 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 125.45 Million USD | 104.39% |
| 2024 Q1 | 125.45 Million USD | -47.03% |
| 2023 Q4 | 268.31 Million USD | 127.87% |
| 2023 FY | - USD | 22.79% |
| 2023 Q1 | 115.95 Million USD | -48.0% |
| 2023 Q2 | 244.04 Million USD | 110.47% |
| 2023 Q3 | 117.75 Million USD | -51.75% |
| 2022 FY | - USD | 2.93% |
| 2022 Q4 | 222.97 Million USD | 108.87% |
| 2022 Q3 | 106.75 Million USD | -47.39% |
| 2022 Q2 | 202.9 Million USD | 97.38% |
| 2022 Q1 | 102.8 Million USD | -43.59% |
| 2021 Q2 | 244.31 Million USD | 117.94% |
| 2021 FY | - USD | -0.12% |
| 2021 Q1 | 112.1 Million USD | -50.22% |
| 2021 Q3 | 90.6 Million USD | -62.92% |
| 2021 Q4 | 182.24 Million USD | 101.15% |
| 2020 FY | - USD | 34.37% |
| 2020 Q2 | 212.13 Million USD | 112.03% |
| 2020 Q3 | 95.3 Million USD | -55.08% |
| 2020 Q4 | 225.18 Million USD | 136.29% |
| 2020 Q1 | 100.05 Million USD | -58.52% |
| 2019 Q1 | 91.4 Million USD | -25.02% |
| 2019 FY | - USD | -31.44% |
| 2019 Q4 | 241.2 Million USD | 131.26% |
| 2019 Q3 | 104.3 Million USD | -46.62% |
| 2019 Q2 | 195.38 Million USD | 113.76% |
| 2018 Q2 | 108.85 Million USD | 0.0% |
| 2018 Q1 | 108.85 Million USD | -18.16% |
| 2018 FY | - USD | -1.86% |
| 2018 Q4 | 121.9 Million USD | 0.0% |
| 2018 Q3 | 121.9 Million USD | 11.99% |
| 2017 Q3 | 133 Million USD | 43.09% |
| 2017 Q2 | 92.95 Million USD | 0.0% |
| 2017 Q1 | 92.95 Million USD | -9.18% |
| 2017 Q4 | 133 Million USD | 0.0% |
| 2017 FY | - USD | 33.46% |
| 2016 Q3 | 102.35 Million USD | 66.69% |
| 2016 Q1 | 101.6 Million USD | 2.73% |
| 2016 Q4 | 102.35 Million USD | 0.0% |
| 2016 Q2 | 61.4 Million USD | -39.57% |
| 2016 FY | - USD | -15.49% |
| 2015 FY | - USD | 2.82% |
| 2015 Q4 | 98.9 Million USD | -15.25% |
| 2015 Q3 | 116.7 Million USD | 5.61% |
| 2015 Q2 | 110.5 Million USD | 5.04% |
| 2015 Q1 | 105.2 Million USD | 7.02% |
| 2014 Q1 | 109.7 Million USD | -24.6% |
| 2014 FY | - USD | -22.19% |
| 2014 Q2 | 132.19 Million USD | 20.51% |
| 2014 Q4 | 98.3 Million USD | -31.21% |
| 2014 Q3 | 142.9 Million USD | 8.09% |
| 2013 Q3 | 147.6 Million USD | 10.4% |
| 2013 Q2 | 133.69 Million USD | 26.61% |
| 2013 FY | - USD | 5.76% |
| 2013 Q4 | 145.5 Million USD | -1.42% |
| 2013 Q1 | 105.6 Million USD | -40.57% |
| 2012 Q4 | 177.7 Million USD | 64.23% |
| 2012 Q3 | 108.2 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 47353.292% |
| Ansell Limited | 209.86 Million USD | -117.048% |
| Ansell Limited | 206.3 Million USD | -120.795% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -963.264% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 28131.614% |
| Psykey, Inc. | -1.29 Million USD | 35265.49% |
| ConvaTec Group Plc | 455.5 Million USD | 0.0% |
| Encision Inc. | -544.19 Thousand USD | 83801.614% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 321304.428% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 414454.589% |
| Innovative MedTech Inc. | -7.67 Million USD | 6035.768% |
| LifePoint, Inc. | -14.2 Million USD | 3307.264% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 7462.211% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 140253.846% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 211730.133% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 112351.838% |
| SmileDirectClub, Inc. | -186.13 Million USD | 344.71% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -1.714% |
| SheerVision, Inc. | -110.53 Thousand USD | 412201.582% |
| United Health Products, Inc. | -2.5 Million USD | 18303.879% |
| Vasamed, Inc. | -4.57 Million USD | 10057.499% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 20248.306% |
| Yubo International Biotech Limited | -1.17 Million USD | 38777.542% |